Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Am J Physiol Renal Physiol. 2013 Aug 1;305(3):F255-64. doi: 10.1152/ajprenal.00160.2013. Epub 2013 May 29.
Mitochondria are both a source and target of the actions of reactive oxygen species and possess a complex system of inter-related antioxidants that control redox signaling and protect against oxidative stress. Interestingly, the antioxidant enzyme heme oxygenase-1 (HO-1) is not present in the mitochondria despite the fact that the organelle is the site of heme synthesis and contains multiple heme proteins. Detoxification of heme is an important protective mechanism since the reaction of heme with hydrogen peroxide generates pro-oxidant ferryl species capable of propagating oxidative stress and ultimately cell death. We therefore hypothesized that a mitochondrially localized HO-1 would be cytoprotective. To test this, we generated a mitochondria-targeted HO-1 cell line by transfecting HEK293 cells with a plasmid construct containing the manganese superoxide dismutase mitochondria leader sequence fused to HO-1 cDNA (Mito-HO-1). Nontargeted HO-1-overexpressing cells were generated by transfecting HO-1 cDNA (HO-1) or empty vector (Vector). Mitochondrial localization of HO-1 with increased HO activity in the mitochondrial fraction of Mito-HO-1 cells was observed, but a significant decrease in the expression of heme-containing proteins occurred in these cells. Both cytosolic HO-1- and Mito-HO-1-expressing cells were protected against hypoxia-dependent cell death and loss of mitochondrial membrane potential, but these effects were more pronounced with Mito-HO-1. Furthermore, decrement in production of tricarboxylic acid cycle intermediates following hypoxia was significantly mitigated in Mito-HO-1 cells. These data suggest that specific mitochondrially targeted HO-1 under acute pathological conditions may have beneficial effects, but the selective advantage of long-term expression is constrained by a negative impact on the synthesis of heme-containing mitochondrial proteins.
线粒体既是活性氧物质作用的来源,也是其作用的靶点,并且拥有一套复杂的相互关联的抗氧化系统,可控制氧化还原信号并防止氧化应激。有趣的是,尽管细胞器是血红素合成的部位且含有多种血红素蛋白,但抗氧化酶血红素加氧酶-1(HO-1)并不存在于线粒体中。血红素的解毒是一种重要的保护机制,因为血红素与过氧化氢的反应会生成促氧化剂铁氧物种,能够引发氧化应激并最终导致细胞死亡。因此,我们假设定位于线粒体的 HO-1 具有细胞保护作用。为了验证这一点,我们通过转染含有锰超氧化物歧化酶线粒体前导序列融合到 HO-1 cDNA 的质粒构建体(Mito-HO-1),生成了一个线粒体靶向 HO-1 的细胞系。通过转染 HO-1 cDNA(HO-1)或空载体(Vector)生成非靶向 HO-1 过表达细胞。在 Mito-HO-1 细胞的线粒体部分观察到 HO-1 活性增加的 HO-1 线粒体定位,但这些细胞中血红素蛋白的表达显著下降。表达胞质 HO-1 和 Mito-HO-1 的细胞都能抵抗缺氧依赖性细胞死亡和线粒体膜电位丧失,但 Mito-HO-1 的效果更为明显。此外,Mito-HO-1 细胞中缺氧后三羧酸循环中间产物的产生明显减少。这些数据表明,在急性病理条件下,特定的线粒体靶向 HO-1 可能具有有益作用,但长期表达的选择性优势受到对含血红素线粒体蛋白合成的负面影响的限制。